Successful treatment of kasabach-merritt syndrome with vincristine and surgery: a case report and review of literature

Table 1 Relevant haematological investigations carried out during hospital stay and follow-up at outpatients' department of MCH.

Hospital stay	Investigations				Treatment
	WBC/cmm	Hb gm %	Platelet/cmm	Others
1^st day	8000	10.6	94000
4^th day	11900	11.4	5000	PT > 100 sec (N = 28.8) PTT > 120 sec (N = 34.8) Fibrinogen = 19.7 mg/dl (N = 160–350)	Prednisolone
7^th day	9300	9.0	4000
5^th week	8200	9.7	6000	PT > 100 sec (N = 28.8) PTT > 120 sec (N = 34.8) Fibrinogen = 42.3 mg/dl (N = 160–350)	Vincristine
7^th week	10400	10.2	19000
9^th week	9500	9.8	45000
11^th week	8500	10.7	49000
13^th week	9500	11.2	50000		Surgery
4^th month (OPD)	10200	10.9	278000	PT = 16.5 sec (N = 28.8) PTT = 34.2 sec (N = 34.8) Fibrinogen = 236 mg/dl (N = 160–350)
8^th month (OPD)	5900	11.0	290000	PT = 16.2 sec (N = 28.8) PTT = 27.8 sec (N = 34.8) Fibrinogen = 251 mg/dl (N = 160–350)